Five recent Parkinson’s disease drug target discoveries
This article highlights five of the latest findings that could be used in the development or design of new therapies to treat Parkinson’s disease.
List view / Grid view
This article highlights five of the latest findings that could be used in the development or design of new therapies to treat Parkinson’s disease.
The process of Salmonella typhi to damage DNA has been revealed by researchers at the University of Sheffield which could inform treatments.
Researchers discover that a non-coding region of the genome originates a key molecule for the proliferation of cancerous tumours.
An animal model to test HIV infection in infants could lead to biomarkers that predict viral rebound after ART interruption.
A compound that promotes the rebuilding of the protective sheath around nerve cells damaged in multiple sclerosis has been developed.
The UK Brain Banks Network has been enhanced to include genomic data, which can be accessed by researchers worldwide.
A research team has found that blocking a particular kinase in a mouse model of arrhythmogenic cardiomyopathy led to improved survival rates.
Researchers have created a vaccine to treat and prevent streptococcal toxic shock syndrome which showed success in mice models.
A new study has demonstrated the possibility of treating antibiotic-resistant Pseudomonas aeruginosa which causes sepsis in burn patients.
A report from scientists at the Moscow Institute of Physics and Technology highlights the advantages and disadvantages of serial femtosecond X-ray crystallography. This article investigates the review, focusing on its role in drug development.
New research is the first to link maladaptive changes in calcium transport by mitochondria to the progression of Alzheimer's disease.
The British Journal of Pharmacology has recommended that all studies it publishes should address sex as an experimental variable.
Scientists combine organ-on-a-chip and stem-cell technologies to make a powerful tool for diabetes research.
Scientists have shown that drug-resistant bacteria infections shut out antibiotics by closing tiny doors in their cell walls.
Researchers have found a new way to treat the inflammation involved in chronic diseases.